Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2720]
News [7073]
Articles [272]
Editorials [8]
Conferences [215]
elearning [41]
Even late progressors with high risk factors in PRIMA prognostic index are more...
Prof Marek Trněný - Charles University, Prague, Czech Republic
Even late progressors with high risk factors in PRIMA prognostic index are more likely to die ( Prof Marek Trněný - Charles University, Prague, Czech Republic )
17 Jun 2018
Patient relevant outcomes and advocacy
Jan Geissler - CML Advocates Network, EuroBloodNET ePAG
Patient relevant outcomes and advocacy ( Jan Geissler - CML Advocates Network, EuroBloodNET ePAG )
17 Jun 2018
The mutational landscape of AML
Prof Lars Bullinger - Charité University of Berlin, Berlin, Germany
The mutational landscape of AML ( Prof Lars Bullinger - Charité University of Berlin, Berlin, Germany )
17 Jun 2018
Lymphoma guidelines in Venezuela
Dr Maria Alejandra Torres Viera - Clínica Santa Sofía, Caracas, Venezuela
Lymphoma guidelines in Venezuela ( Dr Maria Alejandra Torres Viera - Clínica Santa Sofía, Caracas, Venezuela )
16 Jun 2018
Brentuximab vedotin with chemo for relapsed Hodgkin lymphoma
Dr Ramon Garcia Sanz - Hospital Universitario de Salamanca, Salamanca, Spain
Brentuximab vedotin with chemo for relapsed Hodgkin lymphoma ( Dr Ramon Garcia Sanz - Hospital Universitario de Salamanca, Salamanca, Spain )
16 Jun 2018
EHA 2018: Research, collaboration and working towards cures
Prof Pieter Sonneveld - Erasmus MC, Rotterdam, Holland
EHA 2018: Research, collaboration and working towards cures ( Prof Pieter Sonneveld - Erasmus MC, Rotterdam, Holland )
16 Jun 2018
Educational focus on immunotherapy at EHA
Prof John Gribben - Barts Cancer Institute, London, United Kingdom
Educational focus on immunotherapy at EHA ( Prof John Gribben - Barts Cancer Institute, London, United Kingdom )
16 Jun 2018
ADC polatuzumab vedotin in combinations for relapsed lymphoma
Dr Laurie Sehn - BC Cancer Agency, Vancouver, Canada
ADC polatuzumab vedotin in combinations for relapsed lymphoma ( Dr Laurie Sehn - BC Cancer Agency, Vancouver, Canada )
16 Jun 2018
iNNOVATE trial of added ibrutinib for Waldenströms Macroglobulinemia
Dr Meletios Dimopoulos - National and Kapodistrian University of Athens School...
iNNOVATE trial of added ibrutinib for Waldenströms Macroglobulinemia ( Dr Meletios Dimopoulos - National and Kapodistrian University of Athens School of Medicine, Athens, Greece )
16 Jun 2018
EHA 2018: Initial results of the INSIGHT trial in multiple myeloma
Prof Efstathios Kastritis and Dr Zhengzheng Fu
EHA 2018: Initial results of the INSIGHT trial in multiple myeloma ( Prof Efstathios Kastritis and Dr Zhengzheng Fu )
16 Jun 2018
EHA 2018: The unmet needs in maintenance therapy for multiple myeloma
Prof Meletios Dimopoulos, Dr Shaji Kumar, Prof Meral Beksaç and Prof Wee Joo...
EHA 2018: The unmet needs in maintenance therapy for multiple myeloma ( Prof Meletios Dimopoulos, Dr Shaji Kumar, Prof Meral Beksaç and Prof Wee Joo Chng )
15 Jun 2018
EHA 2018: Results of the OPTIMISMM trial
Prof Paul Richardson - Dana-Farber Cancer Institute, Boston, USA
EHA 2018: Results of the OPTIMISMM trial ( Prof Paul Richardson - Dana-Farber Cancer Institute, Boston, USA )
15 Jun 2018

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation